Skip to main content
. Author manuscript; available in PMC: 2020 Nov 30.
Published in final edited form as: Gastric Cancer. 2017 Jun 22;21(1):74–83. doi: 10.1007/s10120-017-0743-4

Table 1.

Patient and tumor characteristics (n = 354)

Variable No. of patients (%) (n = 354)
Age ≥65 years 142 (40)
Sex Female 141 (40)
Male 213 (60)
Race/ethnicity White 196 (55)
Black 34 (10)
Asian 39 (11)
Hispanic/Latino 85 (24)
Surgery year 1995–2005 134 (38)
2006–2015 220 (62)
Histology grade (n = 328) Well differentiated 1 (0.3)
Moderately differentiated 76 (23)
Poorly differentiated 251 (77)
Signet-ring cells Yes 180 (51)
Linitis plastica Yes 21 (6)
Suspicious 14(4)
Location GEJ 78 (22)
Cardia/fundus 36 (10)
Body 173 (49)
Antrum 67 (19)
Type of resection Total gastrectomy 193 (54)
Subtotal gastrectomy 144 (41)
Proximal gastrectomy 17 (5)
Preoperative therapy Yes 354 (100)
Chemoradiation 265 (75)
Postoperative therapy Yes 56 (16)
Concomitant organ resection Yes 58 (16)
Pancreatectomy 19 (5)
Splenectomy 20 (6)
Hepatectomy 25 (7)
Colon/small bowel 10 (3)
Extent of lymph node (LN) dissection = D1+/D2 Yes 304 (86)
Number of LNs examined ≥16 Yes 259 (73)
Postoperative mortality <90 days Yes 9 (2.5)
cT category 1a/1b 0 (0)
2 53 (15)
3/4a 274 (77)
4b 27 (8)
cN category Negative 159 (45)
Positive 195 (55)
ypT category 0 56 (16)
1a/1b 57 (16)
2 67 (19)
3 124 (35)
4a 36 (10)
4b 14 (4)
ypN category 0 202 (57)
1 79 (22)
2 36 (10)
3 37 (10)
ypM category 0 336 (95)
1 18 (5)
Residual tumor R0 316 (94)
[n = 336 (ypM0)] R1 20 (6)